Given the current weak deposit growth trends and elevated C-D ratio levels, we reduce Axis Bank's FY25/26/27 loan growth estimates to 9%/12%/11% from 12%/13%/14% estimates earlier.
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Systematix Research Report
Axis Bank Ltd. reported Q3 FY25 profit after tax of Rs 63 billion which declined by -9% QoQ, +4% YoY mainly due to-
weak net interest income growth (1% QoQ, 9% YoY) led by margin compression and weak loan growth,
weak other income growth (-11% QoQ) on strong base,
higher credit costs on higher retail slippages,'partly offset by opex decline (-5% QoQ, +1% YoY).
Given that credit-deposit ratio will remain elevated and retail slippages are yet to peak out, earnings are likely to remain under pressure in near term, albeit Q4 will benefit from favorable seasonality.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Buy, Sell Or Hold: Bajaj Finserv, Hinduja Global, Vedanta, Power Grid, Piramal Pharma — Ask Profit


Metals, Mining Q1 Results Review— Inline Show; Tata Steel, JSW Steel, NMDC Among Systematix' Top Picks


'Buy' Infosys, LTIMindtree, 'Hold' TCS, Cyient Among Others Recommends Anand Rathi; IT Services Q1 Review


Britannia Q1 Review: Steady Growth Drivers In Place; Stock Upside Still Limited — Systematix Maintains Hold
